Trial Profile
Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Antineoplastics; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms MATEO
- 21 Sep 2020 Recruitment was stopped prematurely due to delayed accrual and emerging new therapeutical options, as per results presented at the 45th European Society for Medical Oncology Congress.
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress.
- 05 Aug 2019 Status changed from recruiting to completed.